• About
  • Services
  • News and Updates
  • Definitions
  • Careers
  • Contact
  • Locations
    • LinkedIn
3PBIOVIAN
  • Proteins
    • Microbial Proteins
    • Mammalian Proteins
  • Viral Vectors
    • AAV Manufacturing
    • Adenovirus Manufacturing
    • AAVion® Platform
  • Plasmid DNA
  • Cell Therapies
  • Other Services
    • Aseptic Fill & Finish
    • QC Services
    • Conjugated Biotherapeutics
Pirjo Merilahti

Pirjo Merilahti

Technology Manager for Gene Therapy Manufacturing & Development at 3PBIOVIAN’s Turku

From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing

July 8, 2026

Read more >

Process development, scale-up and challenges of TM adenovirus GMP process in the iCELLis

July 8, 2026

Read more >

Say hello.

Passionate about progress and people, we work in harmony with our partners, always close, all the way.

"*" indicates required fields

By submitting this form, 3P BIOPHARMACEUTICALS, S.L.U. will use the personal data you provide us with to send you the requested information. It is hereby informed that the services of this website are intended for adults (individuals who have reached the legal age). You may withdraw your consent at any time by notifying us at complianceofficer@3pbio.com. Such withdrawal will not affect the lawfulness of any processing based on consent given prior to its withdrawal.

Consent Privacy Policy*
Consent Newsletter*

Services

  • Proteins
    • Microbial Proteins
    • Mammalian Proteins
  • Viral Vectors
    • AAV Manufacturing
    • Adenovirus Manufacturing
    • AAVion® Platform
  • Plasmid DNA
  • Cell Therapies
  • Other Services
    • Aseptic Fill & Finish
    • QC Services
    • Conjugated Biotherapeutics

Company

  • About us
  • Contact
  • Careers

Legal

  • Privacy Policy
  • Cookies Policy
  • Whistleblower Policy
  • Legal Notice
  • LinkedIn
3PBIOVIAN

© 3PBIOVIAN 2024